About WuXi Diagnostics
WuXi Diagnostics is a company based in Rochester (United States) founded in 2018.. WuXi Diagnostics has raised $200 million across 2 funding rounds from investors including Thermo Fisher Scientific, Shiyu Capital and ABC International Holdings. WuXi Diagnostics operates in a competitive market with competitors including BioSerenity, QuidelOrtho, NuvoAir, MedTel Healthcare and ProciseDx, among others.
- Headquarter Rochester, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$200 M (USD)
in 2 rounds
-
Latest Funding Round
$150 M (USD), Series B
Feb 23, 2021
-
Investors
Thermo Fisher Scientific
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of WuXi Diagnostics
WuXi Diagnostics has successfully raised a total of $200M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $150 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $150.0M
-
First Round
First Round
(01 Oct 2019)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series B - WuXi Diagnostics | Valuation |
investors |
|
| Oct, 2019 | Amount | Series A - WuXi Diagnostics | Valuation | Yunfeng Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in WuXi Diagnostics
WuXi Diagnostics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, Shiyu Capital and ABC International Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Shiyu Capital is engaged in equity investment and asset allocation.
|
Founded Year | Domain | Location | |
|
Private equity investments are managed by Yunfeng Capital in China.
|
Founded Year | Domain | Location | |
|
Sunland Capital is focused on early-stage healthcare industry investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by WuXi Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - WuXi Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wuxi Diagnostics Comparisons
Competitors of WuXi Diagnostics
WuXi Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioSerenity, QuidelOrtho, NuvoAir, MedTel Healthcare and ProciseDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| domain | founded_year | HQ Location |
Provider of healthcare information services
|
|
| domain | founded_year | HQ Location |
Clinical decision support tools for respiratory diseases are provided.
|
|
| domain | founded_year | HQ Location |
Remote patient monitoring software is developed for healthcare providers.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
|
| domain | founded_year | HQ Location |
ICT-based products and solutions are developed for healthcare.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Wuxi Diagnostics
Frequently Asked Questions about WuXi Diagnostics
When was WuXi Diagnostics founded?
WuXi Diagnostics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is WuXi Diagnostics located?
WuXi Diagnostics is headquartered in Rochester, United States.
Who is the current CEO of WuXi Diagnostics?
Jason Liu is the current CEO of WuXi Diagnostics.
Is WuXi Diagnostics a funded company?
WuXi Diagnostics is a funded company, having raised a total of $200M across 2 funding rounds to date. The company's 1st funding round was a Series A of $50M, raised on Oct 01, 2019.
What does WuXi Diagnostics do?
Founded in 2018 and based in Rochester, United States, WuXi Diagnostics operates in the healthcare sector. Integrated diagnostic platforms are developed to support hospitals and physicians with data-driven decision-making for various diseases. Multi-platform technical and clinical big data are utilized, alongside products such as the Enabling Solution Package, which applies algorithms for early disease detection and management.
Who are the top competitors of WuXi Diagnostics?
WuXi Diagnostics's top competitors include MedTel Healthcare, QuidelOrtho and Neurosynaptic.
Who are WuXi Diagnostics's investors?
WuXi Diagnostics has 7 investors. Key investors include Thermo Fisher Scientific, Shiyu Capital, ABC International Holdings, Yunfeng Capital, and Feixiang Group.